Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?
Curr Cardiol Rep
; 21(10): 126, 2019 09 07.
Article
em En
| MEDLINE
| ID: mdl-31494770
ABSTRACT
PURPOSE OF REVIEW Drug-coated balloons (DEB) and drug-eluting stents (DES) emerged as a tool to aid in lowering the rates of neointimal hyperplasia and target lesion restenosis following endovascular peripheral arterial disease (PAD) interventions. RECENT FINDINGS:
Although the initial trials comparing these devices with non-drug balloons and stents showed favorable results, more recent data raised concerns regarding the mid to long-term safety of these devices. In this review, we will discuss the evolution of endovascular therapy for PAD, with highlights regarding the recent debates on the long-term safety of the drug-coated devices for treatment of PAD.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fármacos Cardiovasculares
/
Paclitaxel
/
Angioplastia com Balão
/
Materiais Revestidos Biocompatíveis
/
Stents Farmacológicos
/
Doença Arterial Periférica
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article